PAR logo

PAR

PAR Technology Corporation

$22.29
-$2.38(-9.63%)
45
Overall
60
Value
41
Tech
34
Quality
Market Cap
$1.57B
Volume
2.04M
52W Range
$25.97 - $72.60
Target Price
$56.88

Company Overview

Mkt Cap$1.57BPrice$22.29
Volume2.04MChange-9.63%
P/E Ratio-315.3Open$24.61
Revenue$350.0MPrev Close$24.66
Net Income$-5.0M52W Range$25.97 - $72.60
Div YieldN/ATarget$56.88
Overall45Value60
Quality34Technical41

No chart data available

About PAR Technology Corporation

PAR Technology Corporation, together with its subsidiaries, provides omnichannel cloud-based hardware and software solutions to the worldwide. The company offers PUNCHH, an enterprise-grade customer loyalty and engagement solution; PAR ORDERING, an e-commerce platform; PAR RETAIL, a digital engagement software solution; and PLEXURE, an international customer engagement and loyalty platform under the ENGAGEMENT CLOUD. It also provides PAR POS, a point-of-sale solution; TASK, an enterprise-grade technology solution; PAR OPS, which includes Data Central and Delaget; and PAR PAY, such as PAR payment services, and merchant services under the OPERATOR CLOUD. In addition, the company offers point-of-sale terminals and tablets, wireless headsets, drive-thru systems, kitchen display systems, kiosks, printers, payment devices, and other in-store peripherals. Further it provides services, such as hardware repair, installation and implementation, training, and on-site and technical support services. It serves enterprise restaurants, franchisees, and other restaurant outlets and to C-Stores; and other retail customers, including amusement parks, cinemas, cruise lines, spas, casinos, and other ticketing and entertainment venues. The company was founded in 1968 and is headquartered in New Hartford, New York.

Sector: Technology
Industry: Software - Application

Latest News

Paradigm Biopharmaceuticals Director Converts Options Into Shares

Paradigm Biopharmaceuticals ( ($AU:PAR) ) has issued an update. Paradigm Biopharmaceuticals has disclosed a change in the interests of director Pau...

TipRanks Australian Auto-Generated Newsdesk4 hours ago

Paradigm Biopharmaceuticals Seeks ASX Quotation for Additional Ordinary Shares

TipRanks Australian Auto-Generated Newsdesk18 hours ago

Exchange Seeks Clarification After Surge in Sun Pharma Advanced Research Trading Volume

TipRanks India Auto-Generated Newsdesk3 days ago

Parker-Hannifin Lifts Outlook After Record Quarter

TipRanks Auto-Generated Newsdesk4 days ago

Wells Fargo Sticks to Their Buy Rating for Parker Hannifin (PH)

TipRanks Auto-Generated Intelligence Newsdesk4 days ago
ABCD
1SymbolPriceChangeVol
2PAR$22.29-9.6%2.04M
3
4
5
6

Get PAR Technology Corporation Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.